for the main comparison.
Dietary Advice compared with no advice for schizophrenia | ||||||
Patient or population: participants with schizophrenia Settings: hospital or community Intervention: dietary advice Comparison: no dietary advice | ||||||
Outcomes | Illustrative comparative risks* (95% CI) | Relative effect (95% CI) | No of Participants (studies) | Quality of the evidence (GRADE) | Comments | |
Assumed risk | Corresponding risk | |||||
Standard Care | Dietary Advice | |||||
Improvement in nutritional intake | We found no relevant trials and therefore no data were available | |||||
Change in measures of nutritional status: weight (kg), body mass index (kg/ m2), and waist/ hip ratio (cms) | No trial‐based data | |||||
Mental state | No trial‐based data | |||||
Clinically important adverse effects | No trial‐based data | |||||
Measures of physiological function | No trial‐based data | |||||
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: Confidence interval; RR: Risk Ratio | ||||||
GRADE Working Group grades of evidence High quality: Further research is very unlikely to change our confidence in the estimate of effect. Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. Very low quality: We are very uncertain about the estimate. |